Fast-tracked CTL: rapid induction of potent anti-tumor killer T cells in situ. (Q51974680)

19 April 2018

https://doi.org/10.1002/eji.200637002

1 reference

29 December 2023

title

Fast-tracked CTL: rapid induction of potent anti-tumor killer T cells in situ. (English)

1 reference

19 April 2018

author

Kevin Pavelko

4

1 reference

19 April 2018

author name string

Karin L Heckman

1

1 reference

19 April 2018

Erin L Schenk

2

1 reference

19 April 2018

Suresh Radhakrishnan

3

1 reference

19 April 2018

Michael J Hansen

5

1 reference

19 April 2018

Larry R Pease

6

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 July 2007

1 reference

19 April 2018

European Journal of Immunology

published in

1 reference

19 April 2018

volume

37

1 reference

19 April 2018

issue

7

1 reference

19 April 2018

page(s)

1827-1835

1 reference

19 April 2018

Breaking tolerance in cancer immunotherapy: time to ACT.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Adoptive-cell-transfer therapy for the treatment of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Adoptive T cell therapy of solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

RETRACTED: B7-DC cross-linking restores antigen uptake and augments antigen-presenting cell function by matured dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

T cell receptor antagonist peptides induce positive selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Strategies of antigen-specific T-cell-based immunotherapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

CD8+ T Cell Effector Mechanisms in Resistance to Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Introduction of soluble protein into the class I pathway of antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Dendritic cells activated by cross-linking B7-DC (PD-L2) block inflammatory airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

7 January 2021

Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

7 January 2021

Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells: dependence on TCR:peptide-MHC interaction, ICAM-1, IL-12, and IFN-gamma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

7 January 2021

Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

7 January 2021

B7-DC/PD-L2 cross-linking induces NF-kappaB-dependent protection of dendritic cells from cell death

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

7 January 2021

Early and multifocal tumors in breast, salivary, Harderian and epididymal tissues developed in MMTY-Neu transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

7 January 2021

DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

7 January 2021

Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

7 January 2021

Immunoediting of cancers may lead to epithelial to mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200637002

7 January 2021

Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/EJI.200637002

Identifiers

DOI

10.1002/EJI.200637002

1 reference

19 April 2018

PubMed ID

17549735

1 reference

19 April 2018